ClinicalTrials.gov record
Completed Phase 2 Interventional

AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure

ClinicalTrials.gov ID: NCT01474135

Public ClinicalTrials.gov record NCT01474135. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 5:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-masked, Randomized, Controlled Study Assessing the Safety and Ocular Hypotensive Efficacy of Two AR 12286/Travoprost Fixed-dose Combination Products Compared to Travatan® Z in Patients With Elevated Intraocular Pressure

Study identification

NCT ID
NCT01474135
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aerie Pharmaceuticals
Industry
Enrollment
93 participants

Conditions and interventions

Interventions

  • 0.004% Travoprost Drug
  • 0.25% AR-12286 / 0.004% travoprost Drug
  • 0.5% AR-12286, 0.004% travoprost Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2011
Primary completion
Mar 31, 2012
Completion
Mar 31, 2012
Last update posted
Sep 22, 2016

2011 – 2012

United States locations

U.S. sites
9
U.S. states
5
U.S. cities
9
Facility City State ZIP Site status
United Medical Research Institute Inglewood California 90301
Aesthetic Eye Care Institute Newport Beach California 92657
Bacharach practice Petaluma California 94954
Centre For Health Care Poway California 92064
Comprehensive Eye Care St Louis Missouri 63090
Rochester Ophthalmology Group Rochester New York 14618
Glaucoma Consultants of the Capital Region Slingerlands New York 12159
Abrams Eye Center Cleveland Ohio 44115
Cataract & Glaucoma Center El Paso Texas 79902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01474135, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 22, 2016 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01474135 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →